B of A Securities Maintains Neutral on Quest Diagnostics, Raises Price Target to $116

B of A Securities maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $110 to $116.

Benzinga · 01/31/2020 16:41

B of A Securities maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $110 to $116.